David Doherty, co-founder of 3G Doctor

Davis Doherty
{"title":"David Doherty, co-founder of 3G Doctor","authors":"Davis Doherty","doi":"10.4155/CLI.15.29","DOIUrl":null,"url":null,"abstract":"D Doherty co-founded 3G Doctor in 2006 as a means of providing patients with a means of private and economical access to the attentions of informed registered doctors. D Doherty’s role involves bringing together feedback from patients and carers, the public, developer communities and technologists to learn how to improve the patient experience, bake in kindness and begin to understand ways in which 3G doctor can deliver and support new care experiences. Interact with D Doherty on Twitter: @mHealth.","PeriodicalId":10369,"journal":{"name":"Clinical investigation","volume":"36 1","pages":"687-689"},"PeriodicalIF":0.0000,"publicationDate":"2015-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical investigation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4155/CLI.15.29","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

D Doherty co-founded 3G Doctor in 2006 as a means of providing patients with a means of private and economical access to the attentions of informed registered doctors. D Doherty’s role involves bringing together feedback from patients and carers, the public, developer communities and technologists to learn how to improve the patient experience, bake in kindness and begin to understand ways in which 3G doctor can deliver and support new care experiences. Interact with D Doherty on Twitter: @mHealth.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
David Doherty, 3G医生的联合创始人
Doherty博士于2006年共同创立了3G医生,为患者提供一种私人和经济的途径,让他们能够得到知情的注册医生的关注。Doherty博士的职责包括汇集来自患者和护理人员、公众、开发者社区和技术专家的反馈,以学习如何改善患者体验,融入善意,并开始了解3G医生如何提供和支持新的护理体验。在Twitter上与D Doherty互动:@mHealth。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Targeting TGF-beta pathway with COVID-19 Drug Candidate ARTIVeda/PulmoHeal Accelerates Recovery from Mild-Moderate COVID-19 A Prospective on Allergic Rhinitis Use of Cladribine for multiple sclerosis treatment: An image article Thalidomide may be an effective medicine for Blau Syndrome Prophylactic administration of a clinically safe low dose of the COVID-19 drug candidate Rejuveinix (RJX) effectively prevents fatal cytokine storm and mitigates inflammatory organ injury in a mouse model of sepsis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1